content top
recent posts

NeurogesX Provides U.S. Regula...

NeurogesX, Inc. (Nasdaq: NGSX) announced that the U.S. Food and Drug Administration (FDA) agreed to its proposed study to evaluate Qutenza(TM) in patients with post-herpetic neuralgia (PHN) following pretreatment with an FDA-approved topical anesthetic.

Save The Date! National Bug Bu...

Campaigning to tackle the massive problem of head lice. Next Monday June 15th 2009, it’s the Department of Health’s National Bug Busting Day. On this day, families everywhere are encouraged to check their hair for traces of head lice...

FDA Warns Consumers Not To Use...

The U.S. Food and Drug Administration announced that Clarcon Biological Chemistry Laboratory Inc. of Roy, Utah, is voluntarily recalling some skin sanitizers and skin protectants marketed under several different brand names because of high levels...

Metastatic Melanoma PV-10 Tria...

Early results of a clinical trial that treated 40 patients with metastatic melanoma using PV-10, a form of the staining compound better known as Rose Bengal, were described as “encouraging” because the drug was well tolerated and...
Dermatology & Cosmetics
recent from Dermatology Save The Date! National Bug Busting Day - Monday June 15th 2009 Campaigning to tackle the massive problem of head lice. Next Monday June 15th 2009, it’s the Department of Health’s National Bug Busting Day. On this day, families everywhere are encouraged to check their hair for traces of head lice and their nits. In support of this Department of...